Pharmacists can be involved in all aspects of care, from deciding treatment plans to educating patients, and in the growing role of oral treatments.
Back
Pharmacy Focus: Oncology Edition
The Pharmacy Focus: Oncology Edition podcast breaks down the latest news and updates for pharmacists in the oncology space. Each month, we speak with experts in the field to bring you the latest research, including discussions of federal policies affecting oncology drug access, overviews of emerging treatments for various cancer types, and recaps of the biggest oncology conferences in the country.
Pharmacy Focus: Oncology Edition
Episodes
All
All
CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).
As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.
This month, we spoke with Bob Luschen, PharmD, clinical coordinator for the pharmacy department at cancer Treatment Centers of America, Atlanta.
This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting.
Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.
In the first episode of Pharmacy Focus: Oncology Edition, we spoke with Ron Lanton, JD, principal at Lanton Law.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
3
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
4
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
5